🇺🇸 FDA

Company profile · Sponsor

Ovid

Ovid Therapeutics

OVID · NYSE pharma NEW YORK, NY, USA
Pipeline
0
Drugs
0
Patents
8

Quick answer

Ovid (OVID) is a pharma company. headquartered in NEW YORK, NY, USA. listed on NYSE. NovaPharmaNews links 0 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker OVID
Exchange NYSE
Company type pharma
Headquarters NEW YORK, NY, USA
SEC CIK 0001636651

Pipeline (0)

No pipeline programs linked yet.

Patents (8)

Search patents →

  1. US 12364708

    Injectable scaffold for treatment of intracranial aneurysms and related technology

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12358968

    Utilization of CD39 and CD103 for identification of human tumor reactive T cells for treatment of cancer

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12336973

    Cancer therapeutic compositions and methods targeting DNAse1L3

    Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12329909

    Airway management systems for pulmonary disorder treatment

    Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12285397

    Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders

    Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12185909

    System and method for cleansing segments of a luminal network

    Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12150461

    Nicotinamide adenine dinucleotide (NAD) compositions, methods of manufacturing thereof, and methods of use thereof

    Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12144801

    Methods and compositions for treatment of epileptic disorders

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Ovid?

Ovid (OVID) is a pharma company. headquartered in NEW YORK, NY, USA. listed on NYSE. NovaPharmaNews links 0 pipeline programs, 0 drugs, and 8 patents to this profile..

Does Ovid have pipeline programs in our database?

No pipeline programs are currently linked to Ovid. Programs may be added as ClinicalTrials.gov sponsor matching improves — check back or search the global pipeline directory.

Where does Ovid company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.